5 minutes with: Dr Katharine Rendle
Dr. Katharine A. Rendle, PhD, MPH is an Assistant Professor of Family Medicine & Community Health and of Epidemiology in the Perelman School of Medicine, […]
screening of high risk populations
“Now this is not the end. It is not even the beginning of the end. but it is, perhaps, the end of the beginning.”
So said Winston Churchill in November 1942. He was of course talking about the Second World War. Today I am thinking about cancer. The launch […]
Bowel cancer surveillance for high-risk patients in the time of COVID-19: What have we learned?
This post was written by Annie Lincoln, Ph.D. Student within the Cancer Prevention Group at King’s College London. Annie is interested in improved colorectal cancer […]
The Ageing Soma, Cancer Evolution & Prevention
James DeGregori is a Professor of Biochemistry and Molecular Genetics at the University of Colorado. His lab seeks to understand how carcinogenic conditions promote cancer […]
The Ageing Soma, Screening and All-Cause Mortality
Paul Pharoah is Professor of Cancer Epidemiology at the University of Cambridge, where he leads research on the molecular pathology of breast and ovarian cancer […]
Best of BEST3: A (not so) hard pill to swallow- an overview of BEST3 & the Cytosponge
The results of the BEST3 trial have just been published and the findings have exceeded even our most optimistic expectations. This trial showed that the […]
A blood test to find over 50 cancers could be the future of early diagnosis
This blog was written by Mairéad Lyons. Mairéad is a Senior Consultant to YouScreen the HPV Self-Sampling study. She has been working in healthcare for […]
Key new evidence that CT screening for lung cancer works
Following the publication of the NELSON trial earlier this month, Dr Rintoul, University Reader in Thoracic Oncology at the University of Cambridge and Honorary Respiratory […]
Which screening guidelines are woefully inadequate?
Following a high-profile article calling for a change in guidelines to make it easier for African Americans to be eligible for lung cancer screening, Prof […]
Sponging the oesophagus to detect cancer earlier
We are celebrating the end of recruitment for the BEST3 Cytosponge™ Trial. In this post the BEST3 team in London and Cambridge tell us about this […]
The Art and Peril of Communicating about Cancer Screening
In this post Hilary Robbins, Scientist at the International Agency for Research on Cancer (IARC), discuses the art of communicating scientific information accurately. Whether or […]